Room2 (MARINE MESSE FUKUOKA Hall A 3F Sub-arena)

Nivo+IPI±Chemo combination therapy ~Evidence and irAE management~

Chair:	Nobuyuki Yamamoto	(Internal Medicine III, Wakayama Medical University)
Speaker:	Hidetoshi Hayashi	(Department of Medical Oncology, Kindai University Faculty of Medicine)

Co-host:

ONO PHARMACEUTICAL CO., LTD./Bristol-Myers Squibb K.K.

Room3 (MARINE MESSE FUKUOKA Hall A 2F Large Meeting Room)

Challenges of Cancer Genome Medicine and expectations for a new panel

Chair:	Noboru Yamamoto	(Department of Experimental Therapeutics, National Cancer Center Hospital)
Speaker:	Daisuke Ennishi	(Department of Hematology and Oncology/Center for Comprehensive Genomic Medicine, Okayama University Hospital)

Co-host:

Illumina K.K.

Room4 (MARINE MESSE FUKUOKA Hall B 1F Exhibition Room)

Treatment strategy for advanced hepatocellular carcinoma in the era of combined immunotherapy

Chair:	Junji Furuse	(Kanagawa Cancer Center)
Speaker:	Makoto Ueno	(Department of Gastroenterology Kanagawa Cancer Center)

Co-host:

Chugai Pharmaceutical Co., Ltd.

Room5 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 1)

Perspective on emerging biomarker-driven therapies in Gastric Cancer.

Chair:	Eishi Baba	(Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University)
Speaker:	Zev A. Wainberg	(Division of Hematology-Oncology David Geffen School of Medicine at UCLA)

Co-host:

Amgen K.K.

Room6 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 2)

Management of metastatic/recurrent HER2 positive breast cancer

Chair:	Hiroji Iwata	(Aichi Cancer Center Department of Breast Oncology)
Speaker:	Yoichi Naito	(Department of General Internal Medicine, National Cancer Center Hospital East, Japan)

Co-host:

DAIICHI SANKYO COMPANY, LIMITED

Room7 (Fukuoka International Congress Center 3F Main Hall)

The future treatment strategies to improve prognosis in EGFRm+ NSCLC

Chair:	Tetsuya Mitsudomi	(Kindai Hospital Global Research Alliance Center)
Speaker:	Pasi A. Jänne	(Dana-Faber Cancer Institute)

Co-host:

AstraZeneca K.K.

Room8 (Fukuoka International Congress Center 2F 201+202)

How to Treat Cancer of Unknown Primary ~ How to use Opdivo, the first anticancer drug covered by insurance for CUP ? ~

Chair:	Kan Yonemori	(Department of Medical Oncology, National Cancer Center Hospital)
Speaker:	Tatsunori Shimoi	(Department of Medical Oncology, National Cancer Center Hospital)

Co-host:

Bristol-Myers Squibb K.K./ONO PHARMACEUTICAL CO., LTD.

Room9 (Fukuoka International Congress Center 2F 203+204)

Comprehensive Treatment Sequence in metastatic Gastric Cancer since the Introduction of ICI in first-line Treatment

Chair:	Kensei Yamaguchi	(Department of Gastroenterological Chemotherapy Cancer Institute Hospital Japanese Foundation for Cancer Research)
Speaker:	Sun Young Rha	(Medical Oncology, Yonsei Cancer Center/Songdang Institute for Cancer Research)

Co-host:

Eli Lilly Japan K.K.

Room10 (Fukuoka International Congress Center 4F 409+410)

Guardant360-guided Precision Oncology

Chair:	Kei Muro	(Department of Clinical Oncology, Aichi Cancer Center Hospital)
Speaker:	Yoshiaki Nakamura	(International Research Support Office/Department of Gastrointestinal Oncology/Translational Research Support Office, National Cancer Center Hospital East)

Co-host:

Guardant Health Japan Corp.

Room11 (Fukuoka International Congress Center 4F 411+412)

Treatment Strategy of relapsed/refractory follicular lymphoma

Chair:	Kazuhito Yamamoto	(Aichi Cancer Center)
Speaker:	John P. Leonard	(Weill Cornell Medical College)

Co-host:

Eisai Co., Ltd.

Room12 (Fukuoka International Congress Center 5F 501)

Topics of immunotherapy for recurrent or metastatic head and neck cancer in clinical practice

Chair:	Naomi Kiyota	(Cancer Center, Kobe University Hospital)
Speaker:	Tanguy Seiwert	(Head and Neck Cancer Oncology Disease Group/Oncology Johns Hopkins University Medical Center)

Co-host:

MSD K.K.

Room13 (Fukuoka International Congress Center 5F 502+503)

Onco-Cardiology - Cooperataion between Hematology and Cardiology -

Chair:	Itaru Matsumura	(Department of Hematology and Oncology, Kinki University Hospital)
Speaker:	Jyunichi Ishida	(Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo)

Co-host:

Otsuka Pharmaceutical Co., Ltd.

Room1 (MARINE MESSE FUKUOKA Hall A 1F Multi-purpose Exhibition Hall)

Rethinking EGFR Mutation-Positive Lung Cancer

Chair:	Kazuhiko Nakagawa	(Department of Medical Oncology, Kindai University, Faculty of Medicine)
Speaker:	Nobuyuki Yamamoto	(Internal Medicine Ⅲ, Wakayama Medical University)

Co-host:

Eli Lilly Japan K.K.

Room2 (MARINE MESSE FUKUOKA Hall A 3F Sub-arena)

Genomics and Immunotherapy: Making Matched Targeted Combination Approach a Clinical Reality

Chair:	Yu Snakawa	(St. Marianna University School of Medicine Department of Clinical Oncology)
Speaker:	Shumei Kato	(Experimental Therapeutics, GI Medical Oncology & Rare Tumor Clinic, Division of Hematology & Oncology and Center for Personalized Cancer Therapy UC San Diego Moores Cancer Center)

Co-host:

CHUGAI PHARMACEUTICAL CO., LTD.

Room3 (MARINE MESSE FUKUOKA Hall A 2F Large Meeting Room)

Correlation between genotype and phenotype - Causative genes and appearance of hereditary cancer –

Chair:	Chikashi Ishioka	(Department of Clinical Oncology,Tohoku University Graduate School of Medicine)
Speaker:	Reiko Yoshida	(Showa University Institute for Clinical Genetics and Genomics)

Co-host:

ACTmed Co., Ltd.

Room4 (MARINE MESSE FUKUOKA Hall B 1F Exhibition Room)

Best practices for late line treatment in mCRC

Chair:	Takayuki Yoshino	(Division for the Promotion of Drug and Diagnostic Development / Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Japan)
Speaker:	Satoshi Yuki	(Department of Gastroenterology and Hepatology, Hokkaido University Hospital)

Co-host:

Bayer Yakuhin, Ltd.

Room5 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 1)

What is and will be the optimal strategy following 1st line CDK4/6 inhibitor for HR-positive/HER2-negative metastatic breast cancer?

Chair:	Hiroji Iwata	(Breast Oncology, Aichi Cancer Center Hospital)
Speaker:	Tetsuhiro Yoshinami	(Center for Cancer Genomics and Personalized Medicine, Osaka University Hospital/Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University)

Co-host:

Pfizer Japan Inc.

Room6 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 2)

Best Practice for Colorectal Cancer Pharmacotherapy

Chair:	Kentaro Yamazaki	(Shizuoka Cancer Center,Division of Gastrointestinal Oncology and Clinical Trial Coordination Unit)
Speaker:	Daisuke Kotani	(National Cancer Center Hospital East Department of Gastrointestinal Oncology)

Co-host:

Merck Biopharma Co., Ltd.

Room7 (Fukuoka International Congress Center 3F Main Hall)

Scientific Exchange Meeting 2023 Advances in Systemic Therapy for Biliary Tract Cancers: From TOPAZ-1 to Targeted Therapies

Chair:	Masafumi Ikeda	(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East)
Speaker:	Robin Kate Kelley	(Helen Diller Family Comprehensive Cancer Center,University of California, San Francisco, USA)

Co-host:

AstraZeneca K.K.

Room8 (Fukuoka International Congress Center 2F 201+202)

The Perspectives of Personalized Medicine in Gastric Cancer

Chair:	Hisateru Yasui	(Department of Medical Oncology, Kobe City Medical Center General Hospital)
Speaker:	Nozomu Machida	(Department of Gastroenterology, Kanagawa Cancer Center)

Co-host:

Astellas Pharma Inc.

Room9 (Fukuoka International Congress Center 2F 203+204)

The perspectives on the treatment of early Triple Negative Breast Cancer

Chair:	Kenji Tamura	(Innovative Cancer Center, Department of medical oncology, Shimane University Hospital)
Speaker:	Fumikata Hara	(Breast Medical Oncology Department, The Cancer Institute Hospital of JFCR)

Co-host:

MSD K.K.

Room10 (Fukuoka International Congress Center 4F 409+410)

Treatment sequence and new therapeutic options in advanced PDAC

Chair:	Makoto Ueno	(Department of Gastroenterology, Kanagawa Cancer Center)
Speaker:	Teresa Macarulla	(Gastrointestinal Tumors Service of the Medical Oncology Service at the University Hospital of Vall d’Hebron)

Co-host:

NIHON SERVIER CO., LTD.

Room11 (Fukuoka International Congress Center 4F 411+412)

The first line chemotherapy of esophageal cancer: How can we achieve long-term survival?

Chair:	Manabu Muto	(Department of Therapeutic Oncology,Graduate School of Medicine,Kyoto University)
Speaker:	Ken Kato	(Department of Head and Neck,Esophageal Medical Oncology, Department of Gastrointestinal Medical Oncology,National Cancer Center Hospital)

Co-host:

ONO PHARMACEUTICAL CO., LTD./Bristol-Myers Squibb K.K.

Room12 (Fukuoka International Congress Center 5F 501)

European and Asian treatment strategies for recurrent/metastatic head and neck cancer - Focus on the contents of ESMO Guideline -

Chair:	Naomi Kiyota	(Kobe University Hospital Cancer Center)
Speaker:	Lisa Licitra	(Fondanzione IRCCS Istituto Nazionale dei Tumori, Milan)

Co-host:

Bristol-Myers Squibb K.K./ONO PHARMACEUTICAL CO., LTD.

Room13 (Fukuoka International Congress Center 5F 502+503)

Team-based medical care + Kampo

Chair:	Masato Takahashi	(Department of Breast Surgery,Hokkaido University Hospital)
Speaker:	“Chemotherapy Support Team” and Kampo
	Yoshiharu Motoo	(Kanazawa Medical University)
	ADME research on Kampo medicines from a regional university to the world ~ERAS and Kampo from the viewpoint of pharmacokinetics~
	Kazuhiro Hanazaki	(Kouchi Medical Shool Hospital)

Co-host:

TSUMURA &CO.

Room1 (MARINE MESSE FUKUOKA Hall A 1F Multi-purpose Exhibition Hall)

Chair:	Kei Muro	(Department of Clinical Oncology, Aichi Cancer Center Hospital)
Speaker:	Expectation for gastric cancer 1st line treatment by CM 649 long term follow up data
	Kensei Yamaguchi	(Department of Gastroenterological Chemotherapy Department of Clinical Trial Planning and Management. Cancer Institute Hospital of Japanese Foundation for Cancer Research)
	Progress and future in the treatment of advanced gastric cancer
	Yelena Y. Janjigian	(Gastrointestinal Oncology Service Memorial Sloan Kettering Cancer Center)

Co-host:

Bristol-Myers Squibb K.K./ONO PHARMACEUTICAL CO., LTD.

Room2 (MARINE MESSE FUKUOKA Hall A 3F Sub-arena)

Applying "Judicious" Immunotherapy -IMFINZI+IMJUDO+Chemotherapy in Clinical Practice-

Chair:	Makoto Maemondo	(Department of Internal Medicine, Division of Pulmonary Medicine, Iwate Medical University)
Speaker:	Satoru Miura	(Department of Internal Medicine, Niigata Cancer Center Hospital)

Co-host:

AstraZeneca K.K.

Room3 (MARINE MESSE FUKUOKA Hall A 2F Large Meeting Room)

Chair:	Tomohiro Nishina	(Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center)
Speaker:	Key points of Adlumiz introduction for cancer cachexia
	Satoshi Hamauchi	(Division of Gastrointestinal Oncology, Shizuoka Cancer Center)

Co-host:

ONO PHARMACEUTICAL CO., LTD.

Room4 (MARINE MESSE FUKUOKA Hall B 1F Exhibition Room)

Chair:	Koichi Takayama	(University Hospital Kyoto Prefectural University of Medicine Pulmonary Medicine)
Speaker:	To provide effective drugs, surely for patients ~our current situation in a hospital without pathologists~
	Akito Hata	(Kobe Minimally invasive Cancer Center Division of Thoracic Oncology)
	Current Evidence of KRAS Mutation-Positive Lung Cancer
	Takaaki Sasaki	(Asahikawa Medical University Hospital Respiratory center)

Co-host:

Amgen K.K.

Room5 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 1)

Treatment strategy for CLL

Chair:	Jun Takizawa	(Department of Hematology, Niigata University Medical & Dental Hospital)
Speaker:	Yasushi Takamatsu	(Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal medicine, Fukuoka University)

Co-host:

Chugai Pharmaceutical Co., Ltd./Nippon Shinyaku Co., Ltd.

Room6 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 2)

Current and Future Treatment Landscape for DLBCL

Chair:	Kazuhito Yamamoto	(Aichi Cancer Center)
Speaker:	Martin Hutchings	(Department of Hematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark)

Co-host:

Genmab K.K.

Room7 (Fukuoka International Congress Center 3F Main Hall)

Development of novel treatment strategy for advanced lung cancer - Targeted therapy and Immunotherapy -

Chair:	Yuichiro Ohe	(Department of Thoracic Oncology, National Cancer Center Hospital)
Speaker:	Tatsuya Yoshida	(Department of Thoracic Oncology, National Cancer Center Hospital)

Co-host:

Eli Lilly Japan K.K.

Room8 (Fukuoka International Congress Center 2F 201+202)

Significance of FGFR inhibitors in biliary tract cancer and management of their adverse events - focusing on skin and nail toxicity

Chair:	Tastuya Ioka	(Oncology Center, Yamaguchi University Hospital)
Speaker:	Reconsidering the Significance of FGFR Inhibitors in Biliary Tract Cancer
	Naoya Kato	(Department of Gastroenterology, Graduate School of Medicine, Chiba University)
	Management of Adverse Events Aimed at Long-Term Administration of FGFR Inhibitors - Focusing on Skin and Nail Toxicity.
	Naoya Yamazaki	(Department of Dermatologic Oncology, National Cancer Center Hospital)

Co-host:

Incyte Biosciences Japan G.K.

Room9 (Fukuoka International Congress Center 2F 203+204)

Considering personalized treatment of ALK/ROS1-positive lung cancer

Chair:	Noboru Yamamoto	(Department of Experimental Therapeutics, National Cancer Center Hospital)
Speaker:	Hidetoshi Hayashi	(Department of Medical Oncology, Kindai University, Faculty of Medicine)

Co-host:

Chugai Pharmaceutical Co., Ltd.

Room10 (Fukuoka International Congress Center 4F 409+410)

Mantle Cell Lymphoma – current treatment standards & new options

Chair:	Kenji Ishitsuka	(Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.)
Speaker:	Won Seog Kim	(Division of hematology-Oncology Sungkyunkwan University School of Medicine, Samsung Medical Center Seoul, Korea)

Co-host:

Janssen Pharmaceutical K.K.

Room11 (Fukuoka International Congress Center 4F 411+412)

Patient Journey in Thyroid Cancer and Genetic Testing in Solid Tumors

Chair:	Shunji Takahashi	(Department of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research)
Speaker:	Management of Thyroid Cancer: New Vistas on the Near Future
	Iwao Sugitani	(Department of Endocrine Surgery, Nippon Medical School)
	Genomic Medicine in Thyroid Cancer
	Makoto Tahara	(Department of Head and Neck Medical Oncology, National Cancer Center Hospital East)

Co-host:

Novartis Pharma K.K. Medical Affairs

Room12 (Fukuoka International Congress Center 5F 501)

Current status and future of chemotherapy induced hair loss reduction effect by scalp cooling system

Chair:	Hiroaki Ueo	(Ueo Breast Cancer Hospital)
Speaker:	Makoto Kato	(Kato breast surgery clinic)

Co-host:

HAIR CLINIC Reve-21 Corporation.

Room13 (Fukuoka International Congress Center 5F 502+503)

Science and treatment strategy for patients with HER2+ AGC

Chair:	Chikashi Ishioka	(Department of Clinical Oncology, Tohoku University Graduate School of Medicine)
Speaker:	Taroh Satoh	(Palliative & Supportive Care Center, Osaka University Hospital.)

Co-host:

DAIICHI SANKYO COMPANY, LIMITED

Room1 (MARINE MESSE FUKUOKA Hall A 1F Multi-purpose Exhibition Hall)

Drug loss in Oncology and Japan decline

Chair:	Toshihiko Doi	(Exploratory Oncology Research & Clinical Trial Center (EPOC), Center for Promotion of Translational Research (CPOT), Department of Experimental Therapeutics/Hospital East National Cancer Center)
Speaker:	Noboru Yamamoto	(Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, JAPAN)

Co-host:

IQVIA JAPAN GROUP

Room2 (MARINE MESSE FUKUOKA Hall A 3F Sub-arena)

Current status of Immune Checkpoint Inhibitor for NSCLC ~Perioperative and Advanced or Metastatic~

Chair:	Isamu Okamoto	(Department of Respiratory Medicine Graduate School of medical Sciences Kyushu University)
Speaker:	Takayasu Kurata	(Department of Thoracic Oncology, Kansai Medical University)

Co-host:

MSD K.K.

Room3 (MARINE MESSE FUKUOKA Hall A 2F Large Meeting Room)

Combat the Diversity of EGFR mutations ~Considerations about Treatment Strategy for EGFR-positive non-small cell lung cancer~

Chair:	Haruko Daga	(Osaka City General Hospital, Medical Oncology)
Speaker:	Satoru Miura	(Niigata Cancer Center Hospital,Department of Internal Medicine)

Co-host:

Nippon Boehringer Ingelheim Co., Ltd.

Room4 (MARINE MESSE FUKUOKA Hall B 1F Exhibition Room)

Revision of the Practical Guideline of Bone Metastasis 2022 - Reconsideration of significance of ambulatory ability in cancer patients

Chair:	Hiroyuki Shibata	(Department of Clinical Oncology, Graduate School of Medicine, Akita University)
Speaker:	Hirotaka Kawano	(Department of Orthopaedic Surgery, Teikyo University School of Medicine)

Co-host:

Pfizer Japan Inc.

Room5 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 1)

Precision Medicine in Leukemia

Chair:	Yosuke Minami	(Department of Hematology, National Cancer Center Hospital East)
Speaker:	Toshihiro Miyamoto	(Department of Hematology, Graduate School of Medical Sciences, Kanazawa University)

Co-host:

CMIC Co., Ltd. / CMIC ShiftZero K.K.

Room6 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 2)

Positioning Lutathera in the multidisciplinary treatment of GEP-NET

Chair:	Junji Furuse	(Kanagawa Cancer Center)
Speaker:	Preparation and management of special measures isolation rooms to initiate PRRT
	Kimiteru Ito	(Department of Diagnostic Radiology, National Cancer Center Hospital)
	How should PRRT be used in patients with GEP-NET?
	Masafumi Ikeda	(Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East)

Co-host:

Novartis Pharma K.K.

Room7 (Fukuoka International Congress Center 3F Main Hall)

Genomics-Based Personalized Colorectal Cancer Treatments

Chair:	Taito Esaki	(Clinical Research Institute, National Hospital Organization Kyushu Cancer Center)
Speaker:	Kentaro Yamazaki	(Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Division of Gastrointestinal Oncology)

Co-host:

ONO PHARMACEUTICAL CO., LTD.

Room8 (Fukuoka International Congress Center 2F 201+202)

Financial Toxicity in Japanese Cancer Treatment: Facts and Measures to Manage the Problem.

Chair:	Noriyuki Katsumata	(Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital)
Speaker:	Financial Toxicity in Japanese Cancer Patients
	Kazunori Honda	(Aichi Cancer Center Hospital)
	The financial situation of cancer patients and how to improve and countermeasures
	Chiharu Kuroda	(Kuroda Chiharu Financial Planner office)

Co-host:

MEIJI YASUDA RESEARCH INSTITUTE, INC.

Room9 (Fukuoka International Congress Center 2F 203+204)

Treatment Strategy for Non-Small Cell Lung Cancer 2023 - Focusing on Atezolizumab

Chair:	Kazuo Kasahara	(Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School)
Speaker:	Nobuyuki Yamamoto	(Internal Medicine III, Wakayama Medical University)

Co-host:

Chugai Pharmaceutical Co., Ltd.

Room10 (Fukuoka International Congress Center 4F 409+410)

The role of anti-EGFR antibodies in metastatic colorectal cancer

Chair:	Yoshito Komatsu	(Department of Cancer Center, Hokkaido University Hospital)
Speaker:	Eiji Shinozaki	(Gastroenterological Chemotherapy Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research)

Co-host:

Takeda Pharmaceutical Company Limited

Room11 (Fukuoka International Congress Center 4F 411+412)

Toward Clinical Introduction of Idylla™ System ~ Aiming to Shorten Turnaround time of Genetic Testing ~

Chair:	Yasushi Yatabe	(Department of Diagnostic Pathology, National Cancer Center Hospital)
Speaker:	Kazuto Nishio	(Department of Genome Biology, Kindai University Faculty of Medicine)

Co-host:

NICHIREI BIOSCIENCES INC.

Room12 (Fukuoka International Congress Center 5F 501)

New treatment perspective in HER2 positive metastatic breast cancer. - Enhertu Brings a Bright Future-

Chair:	Kenji Tamura	(Department of Medical Oncology, Shimane University Hospital)
Speaker:	Fumikata Hara	(Japanese Foundation for Cancer Research Cancer Institute Hospital, Breast Medical Oncology)

Co-host:

DAIICHI SANKYO COMPANY, LIMITED

Room13 (Fukuoka International Congress Center 5F 502+503)

Current status and future prospects of genomic medicine in hematologic malignancies

Chair:	Takahiro Maeda	(Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences)
Speaker:	Keisuke Kataoka	(Division of Hematology Department of Medicine Keio University School of Medicine/Division of Molecular Oncology, National Cancer Center Research Institute)

Co-host:

Meiji Seika Pharma Co., Ltd.

Room2 (MARINE MESSE FUKUOKA Hall A 3F Sub-arena)

Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy

Chair:	Yosuke Togashi	(Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University)
Speaker:	Hassane M. Zarour	(Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center Hillman Cancer Center)

Co-host:

Chugai Pharmaceutical Co., Ltd.

Room3 (MARINE MESSE FUKUOKA Hall A 2F Large Meeting Room)

Up-to-date treatment for mCRC ~Treatment strategies considering Fit/Vulnerable~

Chair:	Kei Muro	(Department of Clinical Oncology, Aichi Cancer Center Hospital)
Speaker:	Practice of Continuum of Care in “Vulnerable”
	Yosuke Kito	(Department of Medical Oncology, Ishikawa Prefectural Central Hospital)
	Practice of Continuum of Care in “Fit”
	Tosihiko Matsumoto	(Cancer Treatment Center, Kansai Medical University Hospital)

Co-host:

Taiho Pharmaceutical Co., Ltd.

Room4 (MARINE MESSE FUKUOKA Hall B 1F Exhibition Room)

Why now is the relevant time to review Imfinzi safety ~Taking PMS and other RWEs into account~

Chair:	Kazuhisa Takahashi	(Department of Respiratory Medicine, Juntendo University Faculty of Medicine & Graduate School of Medicine)
Speaker:	Unresectable StageⅢNSCLC
	Takako Inoue	(Department of Thoracic Oncology, Osaka International University)
	Extensive stage SCLC
	Kageaki Watanabe	(Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital)

Co-host:

AstraZeneca K.K.

Room5 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 1)

Treatment of Mantle Cell Lymphoma ~Current Status and Future Prospects~

Chair:	Kazuhito Yamamoto	(Aichi Cancer Center)
Speaker:	Koji Izutsu	(Department of Hematology, National Cancer Center Hospital)

Co-host:

Eli Lilly Japan K.K.

Room6 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 2)

Treatment strategy targeting the Tumor immune Micro Environment (TiME) in Multiple Myeloma：Immune-based Therapy

Chair:	Shinsuke Iida	(Graduate School of Medical Sciences Department of Hematology & Oncology, Nagoya City University)
Speaker:	Yoshiki Akatsuka	(Department of Immunology, Nagoya University Graduate School of Medicine)

Co-host:

Bristol-Myers Squibb K.K.

Room7 (Fukuoka International Congress Center 3F Main Hall)

Immunotherapy for the Treatment of Triple Negative Breast Cancer in Metastatic and Early Stage Disease: Application to the Clinic

Chair:	Junji Tsurutani	(Advanced Cancer Translational Research Institute, Showa University)
Speaker:	Hope S. Rugo	(Breast Oncology and Clinical Trials Education, University of California San Francisco Comprehensive Cancer Center)

Co-host:

MSD K.K.

Room8 (Fukuoka International Congress Center 2F 201+202)

Tramadol for cancer pain and management of breakthrough cancer pain, especially in the settings where there is no specialized palliative care service or strong opioids.

Chair:	Noriyuki Katsumata	(Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital)
Speaker:	Keita Tagami	(Department of Palliative Medicine, Tohoku University Graduate School of Medicine)

Co-host:

Nippon Zoki Pharmaceutical Co., Ltd.

Room9 (Fukuoka International Congress Center 2F 203+204)

Next Step of diagnosis and treatment for NSCLC harboring driver gene alterations

Chair:	Koichi Goto	(National Cancer Center Hospital East, Department of Thoracic Oncology)
Speaker:	Tomohiro Sakamoto	(Division of Respiratory Medicine and Rheumatology, Faculty of Medicine, Tottori University)

Co-host:

Novartis Pharma K.K.

Room10 (Fukuoka International Congress Center 4F 409+410)

Risk management of the Tumor lysis syndrome ~Focus on Hematological Malignancies~

Chair:	Michihide Tokuhira	(Department of Hematology, JCHO Saitama Medical Center)
Speaker:	Takahiro Yamauchi	(Department of Hematology and Oncology, University of Fukui)

Co-host:

Sanofi K.K

Room11 (Fukuoka International Congress Center 4F 411+412)

Essential Rules for Success in Cancer Precision Medicine

Chair:	Akira Hirasawa	(Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Clinical Genomic Medicine)
Speaker:	CGP: Roles and efforts of pathologists, clinical technologists, and pharmacists
	Hiroshi Nishihara	(Genomics Unit, Keio Cancer Center, Keio University School of Medicine)
	CGP: Roles and efforts of nurses and Certified Genetic Counselors
	Hiroko Fujita	(Japanese Red Cross Society Himeji Hospital/Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Clinical Genomic Medicine)

Co-host:

Incyte Biosciences Japan G.K.

Room12 (Fukuoka International Congress Center 5F 501)

What onclogists need to know about pain relief for cancer patients 〜How to successfully use weak opioid analgesics〜

Chair:	Isamu Okamoto	(Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University)
Speaker:	Hiroshi Ueno	(Departments of Pain Management and Palliative Care Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan)

Co-host:

Pfizer Japan Inc.

Room13 (Fukuoka International Congress Center 5F 502+503)

Treatment strategies for untreated classical Hodgkin Lymphoma

Chair:	Hirokazu Nagai	(National Hospital Organization Nagoya Medical Center)
Speaker:	Akihiro Tomita	(Department of Hematology, Fujita Health University School of Medicine)

Co-host:

Takeda Pharmaceutical Company Limited

Room1 (MARINE MESSE FUKUOKA Hall A 1F Multi-purpose Exhibition Hall)

The latest treatment strategies in perioperative EGFR-mutated NSCLC

Chair:	Hidehito Horinouchi	(Department of Thoracic Oncology, National Cancer Center Hospital)
Speaker:	Solange Peters	(Medical Oncology, Lausanne University Hospital(CHUV), Lausanne, Switzerland)

Co-host:

AstraZeneca K.K.

Room2 (MARINE MESSE FUKUOKA Hall A 3F Sub-arena)

CDK 4/6 inhibitor therapy improving breast cancer outcome in early and in metastatic disease

Chair:	Shigehira Saji	(Fukushima Medical University, Department of Medical Oncology)
Speaker:	Nadia Harbeck	(University of München)

Co-host:

Eli Lilly Japan K.K.

Room3 (MARINE MESSE FUKUOKA Hall A 2F Large Meeting Room)

The Latest Treatment Strategies in Esophageal Cancer

Chair:	Kei Muro	(Aichi Cancer Center Hospital)
Speaker:	Ian Chau	(Royal Marsden Hospital, London, UK)

Co-host:

MSD K.K.

Room4 (MARINE MESSE FUKUOKA Hall B 1F Exhibition Room)

Management of irAE myocarditis

Chair:	Satoru Miura	(Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata City, Japan)
Speaker:	Kazuko Tajiri	(Department of Cardiology, National Cancer Center Hospital East)

Co-host:

Bristol-Myers Squibb.K.K./ONO PHARMACEUTICAL CO.,LTD.

Room5 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 1)

Recent Advances in the 1L ALK+ NSCLC treatment Landscape

Chair:	Isamu Okamoto	(Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University)
Speaker:	Maximilian Johannes Hochmair	(Respiratory Oncology Unit Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf)

Co-host:

Takeda Pharmaceutical Company Limited

Room6 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 2)

The Usefulness of the NGS Panel Test in Lung Cancer Treatment

Chair:	Yuichi Takiguchi	(Department of Medical Oncology, Chiba University)
Speaker:	Shunsuke Teraoka	(Wakayama Medical University Pulmonology and Medical Oncology)

Co-host:

Thermo Fisher Scientific

Room7 (Fukuoka International Congress Center 3F Main Hall)

Management of renal disorder associated with cancer pharmacological therapy and selection of appropriate treatment

Chair:	Yutaka Fujiwara	(Department of Thoracic Oncology, Aichi Cancer Center, Aichi, Japan)
Speaker:	Key Points of Revision of "Clinical Practice Guidelines for the Management of Kidney Injury during Anticancer Drug Therapy 2022" (Focusing on checkpoint inhibitors and molecular target drugs)
	Motoko Yanagita	(Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan)

Co-host:

Merck Biopharma Co., Ltd.

Room8 (Fukuoka International Congress Center 2F 201+202)

Minimal residual disease assessment in aggressive B-cell lymphoma

Chair:	Kazuhito Yamamoto	(Aichi Cancer Center)
Speaker:	Noriko Fukuhara	(Tohoku University Hospital)

Co-host:

AbbVie GK

Room9 (Fukuoka International Congress Center 2F 203+204)

Tumor burden monitoring for cancer therapy with circulating tumor DNA using a digital PCR probe library

Chair:	Shigeki Ito	(Division of Hematology & Oncology Department of Internal Medicine, Iwate Medical University School of Medicine)
Speaker:	Satoshi Nishizuka	(Division of Biomedical Research & Development, Iwate Medical University Institute for Biomedical Sciences)

Co-host:

FINGGAL LINK CO.,LTD.

Room10 (Fukuoka International Congress Center 4F 409+410)

G-CSF Up-to-Date

Chair:	Hiroji Iwata	(Aichi Cancer Center,Breast Oncology)
Speaker:	Next steps on how to use G-CSF ~ What is the impact of the New Guideline and New device? ~
	Tetsuhiro Yoshinami	(Center for Cancer Genomics and Personalized Medicine, Osaka University Hospital/Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University)
	The use of G-LASTA Subcutaneous Injection 3.6mg Body Pod ~Support for patients to safely and safely administer drug~
	Hiroe Matsumoto	(Gunma Prefectural Cancer Center, Ambulatory Treatment Center)

Co-host:

Kyowa Kirin Co., Ltd.

Room11 (Fukuoka International Congress Center 4F 411+412)

Transition of treatment development in lung cancer

Chair:	Miyako Satouchi	(Department of Respiratory Medicine, Hyogo Cancer Center)
Speaker:	Technological Innovation in Antibody Drugs - Unraveling the Mechanisms of Diversified Antibody Drugs -
	Kohei Tsumoto	(Department of Bioengineering, School of Engineering, The University of Tokyo)
	Clinical characteristics of EGFR Exon 20 Insertion NSCLC
	Hidetoshi Hayashi	(Department of Medical Oncology, Kindai University School of Medicine)

Co-host:

Medical Affairs, Janssen Pharmaceutical K.K.

Room12 (Fukuoka International Congress Center 5F 501)

Update on the Treatment of Gastric Cancer

Chair:	Masanori Terashima	(Division of Gastric Surgery, Shizuoka Cancer Center)
Speaker:	Taroh Satoh	(Palliative and Supportive Care Center,Osaka University Hospital)

Co-host:

Yakult Honsha Co.,Ltd.

Room13 (Fukuoka International Congress Center 5F 502+503)

Recent advances in perioperative drug therapy in lung cancer.

Chair:	Makoto Nishio	(Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research)
Speaker:	Enriqueta Felip	(Medical Oncology Department, Vall d’Hebron University Hospital. Thoracic Oncology and H&N Cancer Unit)

Co-host:

Chugai Pharmaceutical Co., Ltd.

Room1 (MARINE MESSE FUKUOKA Hall A 1F Multi-purpose Exhibition Hall)

Optimized adjuvant treatment strategy for HER2 negative early breast cancer.

Chair:	Shigehira Saji	(Department of Medical Oncology, Fukushima Medical University)
Speaker:	Tatsunori Shimoi	(Department of Medical Oncology, National Cancer Center Hospital)

Co-host:

AstraZeneca K.K.

Room2 (MARINE MESSE FUKUOKA Hall A 3F Sub-arena)

Cancer genomic medicine moving forward

Chair:	Katsutoshi Oda	(Department of Clinical Genomics, The University of Tokyo Hospital)
Speaker:	To make cancer panel testing more popular
	Kuniko Sunami	(Department of Laboratory Medicine, National Cancer Center Hospital)
	To provide appropriate treatment
	Takafumi Koyama	(Department of Experimental Therapeutics, National Cancer Center Hospital)

Co-host:

Sysmex Corporation

Room3 (MARINE MESSE FUKUOKA Hall A 2F Large Meeting Room)

Front line of personalized therapy for colorectal cancer

Chair:	Eiji Oki	(Department of Surgery and Science, Kyushu University)
Speaker:	Clinical meaning of immune checkpoint inhibitors for MSI-high colorectal cancer
	Toshiki Masuishi	(Department of Clinical Oncology Aichi Cancer Center Hospital)
	Development of treatment strategy based on gene alteration in colorectal cancer
	Hisato Kawakami	(Department of Medical Oncology, Kindai University Faculty of Medicine)

Co-host:

Bristol-Myers Squibb.K.K./ONO PHARMACEUTICAL CO.,LTD.

Room4 (MARINE MESSE FUKUOKA Hall B 1F Exhibition Room)

Chair:	Hiroshi Kitamura	(Department of Urology, Faculty of Medicine, University of Toyama)
Speaker:	Updates of JAVELIN Bladder100 and latest clinical trials in metastatic urothelial carcinoma
	Thomas Powles	(Genitourinary Oncology, Bart’s Cancer Institute, Queen Mary University of London)

Co-host:

Merck Biopharma Co., Ltd./ Pfizer Japan Inc.

Room5 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 1)

Therapeutic Strategies for AML with FLT3 Mutation

Chair:	Shingo Yano	(Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine)
Speaker:	Yuichi Ishikawa	(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)

Co-host:

Astellas Pharma Inc.

Room6 (MARINE MESSE FUKUOKA Hall B 2F Meeting Room 2)

Tumor-agnostic therapy for NTRK fusion-positive solid tumors - Focusing on genomic medicine for sarcoma in Japan and Global-

Chair:	Takayuki Yoshino	(Division for the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East)
Speaker:	Precision medicine & driver mutations in sarcomas
	Jean-Yves Blay	(Centre Léon Bérard, the Comprehensive Cancer Centre of Lyon France)
	Current state of genomic medicine of sarcoma in Japan: Focusing on NTRK fusion-positive sarcomas
	Hiroshi Kobayashi	(Department of Orthopaedic surgery, The University of Tokyo Hospital)

Co-host:

CHUGAI PHARMACEUTICAL CO., LTD.

Room7 (Fukuoka International Congress Center 3F Main Hall)

Considering Treatment with Immune Checkpoint Inhibitors for Advanced NSCLC

Chair:	Katsuyuki Hotta	(Center for Innovative Clinical Medicine, Okayama University Hospital)
Speaker:	Nobuhiko Seki	(Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine)

Co-host:

MSD K.K.

Room8 (Fukuoka International Congress Center 2F 201+202)

Results from TRANSFORM study and implementation of CD19 CAR-T cell treatments in 2L R/R LBCL

Chair:	Koichi Akashi	(Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine)
Speaker:	Stephan Mielke	(Karolinska Institutet)

Co-host:

Bristol-Myers Squibb K.K.

Room9 (Fukuoka International Congress Center 2F 203+204)

How to maximize necitumumab in the age of immunotherapy ~ beyond the immunotherapy ~

Chair:	Akito Hata	(Division of Thoracic Oncology, Kobe Minimally Invasive Cancer Center)
Speaker:	Treatment and management of platinum combination therapy
	Kiichiro Ninomiya	(Center for Comprehensive Genomic Medicine, Okayama University Hospital)
	Reconsidering second-line treatment options for lung squamous cell carcinoma
	Kentaro Ito	(Respiratory Center, Matsusaka Municipal Hospital)

Co-host:

NIPPON KAYAKU CO.,LTD.

Room10 (Fukuoka International Congress Center 4F 409+410)

Optimal driver gene diagnosis and ALK-positive lung cancer treatment discussing with Japanese and American physicians

Chair:	Makoto Nishio	(Thoracic Center, Cancer Institute Hospital of JFCR)
Speaker:	Practice of driver gene diagnosis in NSCLC at our hospital, toward the establishment of an optimal NGS-based diagnostic system
	Kazumi Nishino	(Thoracic Oncology, Osaka International Cancer Institute)
	Updated First-line Therapy for ALK⁺ lung cancer with CROWN study follow up
	Misako Nagasaka	(University of California Irvine School of Medicine, Orange, CA, USA)

Co-host:

Pfizer Japan Inc.

Room11 (Fukuoka International Congress Center 4F 411+412)

Management of metastatic TNBC: latest advances and future directions

Chair:	Hiroji Iwata	(Aichi Cancer Center, Breast Oncology)
Speaker:	Shinji Ohno	(Japan Foundation of Cancer Research, Breast Oncology Center)

Co-host:

Gilead Sciences K.K.

Room12 (Fukuoka International Congress Center 5F 501)

How I Treat AML in 2023: A US Perspective

Chair:	Yosuke Minami	(National Cancer Center Hospital East Department of Hematology)
Speaker:	Naval G Daver	(University of Texas MD Anderson Cancer Center/Department of Leukemia)

Co-host:

Sumitomo Pharma Co., Ltd

Room13 (Fukuoka International Congress Center 5F 502+503)

Supportive Care Advancing Cancer Treatment

Chair:	Nobuyuki Yamamoto	(Division of Respiratory Medicine & Medical Oncology, Wakayama Medical University)
Speaker:	Akihito Tsuji	(Department of Clinical Oncology, Kagawa University Faculty of Medicine)

Co-host:

Taiho Pharmaceutical Co., Ltd.